← Evolent Health, Inc. EVH
Market Price
$4.67
Market Cap
$525.29M
P/E Ratio
N/A
Revenue (FY 2025)
↓-26.6% YoY
$1.88B
3-Yr CAGR: 11.5%
Net Income
↓-767.4% YoY
-$534.51M
Net Margin: -28.5%
Free Cash Flow
↑177.6% YoY
$4.75M
FCF Yield: 0.91%
EPS (Diluted)
↓-525.9% YoY
$-5.07
Basic: $-5.07
Return on Equity
Efficiency
-128.7%
ROA: -2,886.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (EVH)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $254.2M | — | $99.0M | $-159.7M | — | $-3.55 | — | $-35.5M | $-51.0M | — |
| FY 2017 | $434.9M | +71.1% | $165.6M | $-60.7M | +62.0% | $-0.94 | +73.5% | $-28.0M | $-55.8M | -9.3% |
| FY 2018 | $627.1M | +44.2% | $299.2M | $-52.7M | +13.2% | $-0.68 | +27.7% | $-20.7M | $-60.2M | -7.9% |
| FY 2019 | $846.4M | +35.0% | $333.3M | $-302.0M | -473.5% | $-3.67 | -439.7% | $-42.6M | $-78.2M | -29.9% |
| FY 2020 | $1,022.4M | +20.8% | $321.1M | $-334.2M | -10.7% | $-3.94 | -7.4% | $-16.2M | $-45.7M | +41.5% |
| FY 2021 | $908.0M | -11.2% | $250.4M | $-37.6M | +88.8% | $-0.44 | +88.8% | $38.7M | $13.8M | +130.1% |
| FY 2022 | $1,352.0M | +48.9% | $316.6M | $-19.2M | +49.0% | $-0.20 | +54.5% | $-11.6M | $-49.9M | -462.6% |
| FY 2023 | $1,963.9M | +45.3% | $460.5M | $-113.0M | -489.9% | $-1.28 | -540.0% | $142.6M | $113.8M | +328.1% |
| FY 2024 | $2,554.7M | +30.1% | $367.4M | $-61.6M | +45.5% | $-0.81 | +36.7% | $18.8M | $-6.1M | -105.4% |
| FY 2025 | $1,876.2M | -26.6% | $399.9M | $-534.5M | -767.4% | $-5.07 | -525.9% | $38.8M | $4.8M | +177.6% |
Valuation
Market Price
$4.67
Market Cap
$525.29M
Enterprise Value
$1.34B
P/E Ratio
N/A
P/B Ratio
1.27
FCF Yield
0.91%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
21.31%
Operating Margin
-21.86%
Net Margin
-28.49%
Return on Equity (ROE)
-128.74%
Return on Assets (ROA)
-2,885.97%
Asset Turnover
101.30x
Revenue 3-Yr CAGR
11.54%
Financial Health & Liquidity
Current Ratio
0.28
Cash Ratio
2.31
Debt / Equity
2.338
Debt / Assets
52.402
Cash & Equivalents
$151.86M
Total Debt
$970.54M
Book Value / Share
$3.69
Cash Flow Efficiency
Operating Cash Flow
$38.84M
Capital Expenditures (CapEx)
$34.09M
Free Cash Flow
$4.75M
OCF / Revenue
2.07%
FCF / Revenue
0.25%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-5.07
EPS (Basic)
$-5.07
Dividends / Share
N/A
Book Value / Share
$3.69
EPS YoY Growth
-525.93%
Balance Sheet (FY 2025)
Total Assets
$18.52M
Total Liabilities
$65.75M
Stockholders' Equity
$415.19M
Current Assets
$18.52M
Current Liabilities
$65.75M